PP_1170x120_10-25-21

Camille Lee

Novo Nordisk releases Tresiba long-acting insulin

Novo Nordisk releases Tresiba long-acting insulin

PLAINSBORO, N.J. — Novo Nordisk Inc. has rolled out Tresiba, a once-daily, long-acting basal insulin, to U.S. pharmacies. Novo Nordisk said Tuesday that Tresiba (insulin degludec injection), provides a more flexible option for adults with diabetes who require insulin therapy, who often must plan their schedules to accommodate the need to take insulin at the

Adheris Health